Long-term breast cancer risk following ovarian stimulation in young egg donors: a call for follow-up, research and informed consent
- 1 May 2017
- journal article
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 34 (5) , 480-485
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Long-term Relationship of Ovulation-Stimulating Drugs to Breast Cancer RiskCancer Epidemiology, Biomarkers & Prevention, 2014
- IVF and breast cancer: a systematic review and meta-analysisHuman Reproduction Update, 2013
- Meta-Analysis on the Possible Association Between In Vitro Fertilization and Cancer RiskInternational Journal of Gynecological Cancer, 2013
- In vitro fertilization and breast cancer: is there cause for concern?Fertility and Sterility, 2012
- Malignancies among women who gave birth after in vitro fertilizationHuman Reproduction, 2010
- Fatal colon cancer in a young egg donor: a physician mother's call for follow-up and research on the long-term risks of ovarian stimulationFertility and Sterility, 2008
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensionsBritish Journal of Cancer, 2008
- Tumour incidence in Swedish women who gave birth following IVF treatmentHuman Reproduction, 2006
- Breast cancer risk associated with ovulation-stimulating drugsHuman Reproduction, 2004
- Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 2003